Department of Surgery, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
ANZ J Surg. 2020 Jun;90(6):1099-1103. doi: 10.1111/ans.15702. Epub 2020 Jan 26.
Hepatocellular adenoma (HCA) is a hepatocyte derived neoplastic lesion with an increasing incidence and a strong association with oestrogen therapy. Laparoscopic resection has proven safe for small, non-ruptured lesions whilst its use for large adenomas (≥10 cm) and cases of haemorrhage requires further investigation.
All patients undergoing liver resection for HCA at the Royal Brisbane Hospital between January 2003 and April 2018 were analysed. Ethics approval was obtained.
Thirty-three laparoscopic and three open resections were performed in 35 patients, all female, with a median age of 35 years (range 14-75). Nine laparoscopic resections were performed for large adenomas (≥10 cm) and 17 laparoscopic resections were performed for adenomas of intermediate size (5-9.9 cm). Only one conversion to open surgery was required for an intermediate sized tumour. Haemorrhage, either intratumoural, intraparenchymal or free intraperitoneal was the indication for resection in six of the 33 laparoscopic cases. Median operative time was 143 and 266 min for laparoscopically resected intermediate and large lesions, respectively. The median length of stay was 5 days (range 4-9) and no major complications were observed in the laparoscopic group. β-catenin mutation was seen in four of nine large adenomas whereas the inflammatory subtype constituted 11 of 17 intermediate sized lesions.
Laparoscopic surgery has been demonstrated to be safe for the resection of HCA in this group of patients. Importantly, haemorrhage and/or large size were not barriers to laparoscopic resection.
肝细胞腺瘤(HCA)是一种由肝细胞衍生的肿瘤性病变,其发病率不断增加,与雌激素治疗密切相关。腹腔镜切除术已被证明适用于小的、未破裂的病变,而对于大腺瘤(≥10cm)和出血病例,则需要进一步研究。
分析了 2003 年 1 月至 2018 年 4 月期间在皇家布里斯班医院接受肝切除术治疗 HCA 的所有患者。本研究获得了伦理批准。
35 例女性患者中,有 33 例行腹腔镜切除术,3 例行开放性切除术,中位年龄为 35 岁(范围 14-75 岁)。9 例腹腔镜切除术用于治疗大腺瘤(≥10cm),17 例腹腔镜切除术用于治疗中等大小腺瘤(5-9.9cm)。只有 1 例中间大小肿瘤需要转为开放性手术。33 例腹腔镜手术中,有 6 例因肿瘤内、肝内或腹腔内出血而行切除术。腹腔镜切除中等和大肿瘤的中位手术时间分别为 143 分钟和 266 分钟。中位住院时间为 5 天(范围 4-9 天),腹腔镜组无重大并发症发生。9 例大腺瘤中有 4 例存在β-连环蛋白突变,17 例中等大小腺瘤中有 11 例为炎症亚型。
在这组患者中,腹腔镜手术已被证明是安全的 HCA 切除术方法。重要的是,出血和/或肿瘤大并不妨碍腹腔镜切除术。